Faster access than browser!Similarities between Dopaminergic and Methylphenidate
Dopaminergic and Methylphenidate have 31 things in common (in Unionpedia): Addiction, Adverse effect, Amphetamine, Antidepressant, Antipsychotic, Anxiety, Attention deficit hyperactivity disorder, Bipolar disorder, Bupropion, Dopamine, Dopamine reuptake inhibitor, Dopamine transporter, Major depressive disorder, Mesolimbic pathway, Metabolism, Methamphetamine, Monoamine oxidase inhibitor, Monoamine releasing agent, Narcolepsy, Nausea, Neurotransmitter, Opioid, Parkinson's disease, Phenelzine, Phenethylamine, Recreational drug use, Serotonergic, Stimulant, Tranylcypromine, Vesicular monoamine transporter 2, ..., Vomiting. Expand index (1 more) »
Addiction
Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.
Addiction and Dopaminergic · Addiction and Methylphenidate ·
Adverse effect
In medicine, an adverse effect is an undesired harmful effect resulting from a medication or other intervention such as surgery.
Adverse effect and Dopaminergic · Adverse effect and Methylphenidate ·
Amphetamine
Amphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.
Amphetamine and Dopaminergic · Amphetamine and Methylphenidate ·
Antidepressant
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.
Antidepressant and Dopaminergic · Antidepressant and Methylphenidate ·
Antipsychotic
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
Antipsychotic and Dopaminergic · Antipsychotic and Methylphenidate ·
Anxiety
Anxiety is an emotion characterized by an unpleasant state of inner turmoil, often accompanied by nervous behaviour such as pacing back and forth, somatic complaints, and rumination.
Anxiety and Dopaminergic · Anxiety and Methylphenidate ·
Attention deficit hyperactivity disorder
Attention-deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type.
Attention deficit hyperactivity disorder and Dopaminergic · Attention deficit hyperactivity disorder and Methylphenidate ·
Bipolar disorder
Bipolar disorder, previously known as manic depression, is a mental disorder that causes periods of depression and periods of abnormally elevated mood.
Bipolar disorder and Dopaminergic · Bipolar disorder and Methylphenidate ·
Bupropion
Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication primarily used as an antidepressant and smoking cessation aid.
Bupropion and Dopaminergic · Bupropion and Methylphenidate ·
Dopamine
Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is an organic chemical of the catecholamine and phenethylamine families that plays several important roles in the brain and body.
Dopamine and Dopaminergic · Dopamine and Methylphenidate ·
Dopamine reuptake inhibitor
A dopamine reuptake inhibitor (DRI) is a class of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT).
Dopamine reuptake inhibitor and Dopaminergic · Dopamine reuptake inhibitor and Methylphenidate ·
Dopamine transporter
The dopamine transporter (also dopamine active transporter, DAT, SLC6A3) is a membrane-spanning protein that pumps the neurotransmitter dopamine out of the synaptic cleft back into cytosol.
Dopamine transporter and Dopaminergic · Dopamine transporter and Methylphenidate ·
Major depressive disorder
Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.
Dopaminergic and Major depressive disorder · Major depressive disorder and Methylphenidate ·
Mesolimbic pathway
The mesolimbic pathway, sometimes referred to as the reward pathway, is a dopaminergic pathway in the brain.
Dopaminergic and Mesolimbic pathway · Mesolimbic pathway and Methylphenidate ·
Metabolism
Metabolism (from μεταβολή metabolē, "change") is the set of life-sustaining chemical transformations within the cells of organisms.
Dopaminergic and Metabolism · Metabolism and Methylphenidate ·
Methamphetamine
Methamphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity.
Dopaminergic and Methamphetamine · Methamphetamine and Methylphenidate ·
Monoamine oxidase inhibitor
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Dopaminergic and Monoamine oxidase inhibitor · Methylphenidate and Monoamine oxidase inhibitor ·
Monoamine releasing agent
A monoamine releasing agent (MRA), or simply monoamine releaser, is a drug that induces the release of a monoamine neurotransmitter from the presynaptic neuron into the synapse, leading to an increase in the extracellular concentrations of the neurotransmitter.
Dopaminergic and Monoamine releasing agent · Methylphenidate and Monoamine releasing agent ·
Narcolepsy
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles.
Dopaminergic and Narcolepsy · Methylphenidate and Narcolepsy ·
Nausea
Nausea or queasiness is an unpleasant sense of unease, discomfort, and revulsion towards food.
Dopaminergic and Nausea · Methylphenidate and Nausea ·
Neurotransmitter
Neurotransmitters are endogenous chemicals that enable neurotransmission.
Dopaminergic and Neurotransmitter · Methylphenidate and Neurotransmitter ·
Opioid
Opioids are substances that act on opioid receptors to produce morphine-like effects.
Dopaminergic and Opioid · Methylphenidate and Opioid ·
Parkinson's disease
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Dopaminergic and Parkinson's disease · Methylphenidate and Parkinson's disease ·
Phenelzine
Phenelzine (Nardil, Nardelzine) is a non-selective and irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class which is used as an antidepressant and anxiolytic.
Dopaminergic and Phenelzine · Methylphenidate and Phenelzine ·
Phenethylamine
Phenethylamine (PEA) is an organic compound, natural monoamine alkaloid, and trace amine which acts as a central nervous system stimulant in humans.
Dopaminergic and Phenethylamine · Methylphenidate and Phenethylamine ·
Recreational drug use
Recreational drug use is the use of a psychoactive drug to induce an altered state of consciousness for pleasure, by modifying the perceptions, feelings, and emotions of the user.
Dopaminergic and Recreational drug use · Methylphenidate and Recreational drug use ·
Serotonergic
Serotonergic or serotoninergic means "pertaining to or affecting serotonin".
Dopaminergic and Serotonergic · Methylphenidate and Serotonergic ·
Stimulant
Stimulants (also often referred to as psychostimulants or colloquially as uppers) is an overarching term that covers many drugs including those that increase activity of the central nervous system and the body, drugs that are pleasurable and invigorating, or drugs that have sympathomimetic effects.
Dopaminergic and Stimulant · Methylphenidate and Stimulant ·
Tranylcypromine
Tranylcypromine (contracted from trans-2-phenylcyclopropylamine; original trade name Parnate)Drugs.com.
Dopaminergic and Tranylcypromine · Methylphenidate and Tranylcypromine ·
Vesicular monoamine transporter 2
The vesicular monoamine transporter 2 (VMAT2) also known as solute carrier family 18 member 2 (SLC18A2) is a protein that in humans is encoded by the SLC18A2 gene.
Dopaminergic and Vesicular monoamine transporter 2 · Methylphenidate and Vesicular monoamine transporter 2 ·
Vomiting
Vomiting, also known as emesis, puking, barfing, throwing up, among other terms, is the involuntary, forceful expulsion of the contents of one's stomach through the mouth and sometimes the nose.
The list above answers the following questions
- What Dopaminergic and Methylphenidate have in common
- What are the similarities between Dopaminergic and Methylphenidate
Dopaminergic and Methylphenidate Comparison
Dopaminergic has 169 relations, while Methylphenidate has 314. As they have in common 31, the Jaccard index is 6.42% = 31 / (169 + 314).
References
This article shows the relationship between Dopaminergic and Methylphenidate. To access each article from which the information was extracted, please visit:
